-
公开(公告)号:US20240058384A1
公开(公告)日:2024-02-22
申请号:US18501604
申请日:2023-11-03
发明人: Marcela Guzman Ayala
CPC分类号: A61K35/17 , C07K16/303 , A61P35/00 , A61K39/4611 , A61K39/4644 , A61K39/4613 , A61K2239/21 , A61K2239/22 , A61K2239/53 , A61K2239/13
摘要: The present disclosure provides compositions and methods related to chimeric antigen receptors (CARs). In particular, the present disclosure provides CAR-based immunotherapeutic compositions that target tumor cells expressing glypican-3 (GPC3) for the treatment and prevention of cancer.
-
公开(公告)号:US20230272037A1
公开(公告)日:2023-08-31
申请号:US17820804
申请日:2022-08-18
IPC分类号: C07K14/725 , C07K14/705 , C07K14/47 , C12N15/63
CPC分类号: C07K14/7051 , C07K14/70596 , C07K14/4703 , C07K14/70521 , C12N15/63 , C07K2319/03 , C07K2319/02 , C07K2317/622 , C07K2317/55
摘要: Provided herein are inhibitory chimeric antigen receptor compositions and cells comprising such compositions. Also provided are methods of using inhibitory chimeric antigen receptors and cells.
-
公开(公告)号:US20230235051A1
公开(公告)日:2023-07-27
申请号:US17820525
申请日:2022-08-17
发明人: Wilson Wong , Seunghee Lee , Russell Morrison Gordley , Marcela Guzman Ayala , Gary Lee , Nicholas Frankel , Xi Kang
IPC分类号: C07K16/28 , C07K14/725 , C07K14/705 , A61K39/00 , C07K16/32
CPC分类号: C07K16/2803 , C07K14/7051 , C07K14/70517 , C07K14/70521 , A61K39/4611 , A61K39/4621 , A61K39/4631 , A61K39/4643 , A61K39/4613 , C07K16/32 , A61K39/464406 , C07K2319/02 , C07K2319/03 , C07K2317/622 , C07K2319/43 , A61K2239/13 , A61K2239/21 , A61K2239/22
摘要: Provided herein are inhibitory chimeric antigen receptor compositions and cells comprising such compositions. Also provided are methods of using inhibitory chimeric antigen receptors and cells.
-
公开(公告)号:US20230011052A1
公开(公告)日:2023-01-12
申请号:US17838118
申请日:2022-06-10
发明人: Marcela Guzman Ayala , Russell Morrison Gordley , Michelle Elizabeth Hung , Gary Lee , Jack Tzu-Chiao Lin , Timothy Kuan-Ta Lu , Assen Boyanov Roguev
IPC分类号: A61K48/00 , C07K14/005 , A61P35/00 , C07K14/725 , C12N15/63 , C12N15/86 , A61K45/06
摘要: Provided herein are compositions and methods for regulating expression of effector molecules using regulatable transcription factors and/or activation inducible promoters.
-
-
-